Resultados de búsqueda - Musib L
-
1
A First-in-Human Phase I Study of the ATP-Competitive AKT Inhibitor Ipatasertib Demonstrates Robust and Safe Targeting of AKT in Patients with Solid Tumors.
Artículo | por Saura C; Roda D; Roselló S; Oliveira M; Macarulla T; Pérez-Fidalgo JA; Morales-Barrera R; Sanchis-García JM; Musib L; Budha N; Zhu J; Nannini M; Chan WY; Sanabria Bohórquez SM; Meng RD; Lin K; Yan Y; Patel P; Baselga J; Tabernero J; Cervantes A | Publicado 2017 |Otros Autores: “…Musib L…”
-
2
Antitumor activity of ipatasertib combined with chemotherapy: results from a phase Ib study in solid tumors
Artículo | por Isakoff, SJ; Tabernero, J; Molife, LR; Soria, JC; Cervantes, A; Vogelzang, NJ; Patel, MR; Hussain, M; Baron, A; Argiles, G; Conkling, R; Sampath, D; Maslyar, D; Patel, P; Chan, W; Gendreau, S; Musib, L; Xu, N; Ma, H; Lin, K; Bendell, J | Publicado 2020 |Otros Autores: “…Musib, L…”